Roche faces an­oth­er de­lay in strug­gle to nav­i­gate Spark deal past reg­u­la­tors — but this one is very short

Roche to­day is­sued the lat­est in a long string of de­lays of its $4.3 bil­lion buy­out of Philadel­phia-based Spark Ther­a­peu­tics. The de­lay comes as lit­tle sur­prise — it is their 10th in as many months — as their most re­cent de­lay was sched­uled to ex­pire be­fore a key reg­u­la­to­ry dead­line.

But it is no­table for its length: 6 days.

Unlock this article instantly by becoming a free subscriber.

You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.

SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER